miRagen Therapeutics publishes in Cell
April 26, 2012: MiRagen Therapeutics, Inc., a biopharmaceutical company developing innovative microRNA (miRNA)-based therapeutics primarily...
April 26, 2012: MiRagen Therapeutics, Inc., a biopharmaceutical company developing innovative microRNA (miRNA)-based therapeutics primarily...
January 20, 2012 Apama Medical Press Release Over the past six months, we have been...
Boulder, CO-based miRagen has racked up its first big collaboration, inking a development pact with...
CardiaLen Awarded Phase I SBIR Grant Cardiac arrhythmia start-up awarded $216,027 grant to develop a...
CardiaLen receives significant financing from Broadview Ventures CardiaLen receives significant financing from Broadview Ventures to...
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer “As former President and...